DNDM and Unidades Tecnicas: Authorisation and Duties of Technical Units
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Panama’s technical units (Unidades Técnicas) are units inside public or private health institutions that the DNDM has authorised to take part in device management, vigilance and control. Their functions include issuing the technical criteria certificate (CCT) and handling renewals and corrections of the technical verification certificate (CVT). The consequence is that in Panama the CCT is not issued by the DNDM alone: a CCT issued by the DNDM or by an authorised technical unit is valid, but the format must follow the form designed by the DNDM (Article 10, second paragraph of DE 490). Confirming which body will receive the file is the first step in any schedule.
- The CCT can come from the DNDM or from an authorised technical unit; both are valid.
- Authorisation must be granted by resolution, so the status of a technical unit can be verified from the record.
- The form is mandatory and uniform; only the issuing institution’s name changes.
- A reconsideration request does not stay inside the technical unit. It moves the file up to the DNDM.
2. Legal basis
The technical unit is defined in Ley 90, given its operational footing in Articles 8 to 10 of DE 490, and confirmed as a possible issuer of the CCT in Article 21. The provisions are short, but each one carries a checkable fact: who is authorised, by what instrument, on which form, and with what appeal route.
| Ley N° 90 (26 December 2017, Gaceta 28433-B) | Article 6, definition 41 | Technical unit: an administrative unit of a public or private health institution that the DNDM may authorise to take part in the regulation, vigilance and control of devices |
| Ley N° 90 | Article 9 | The DNDM shall promote the integration of device vigilance and control into the organisation and operation of all public and private health facilities, and shall promote the establishment of technical units at regional and local level |
| Decreto Ejecutivo N° 490 (4 October 2019) | Article 8 | The DNDM shall coordinate with health institutions to establish technical units, and must authorise the operation of new and existing technical units by resolution, including the health technology department of the Social Security Fund (CSS) and the central public health reference laboratory of the Gorgas Memorial Institute |
| Decreto Ejecutivo N° 490 | Article 9 | The 5 functions of a technical unit authorised to issue the CCT |
| Decreto Ejecutivo N° 490 | Article 10 | The DNDM sets procedures, processes, guides, operating manuals and forms by resolution; the form designed by the DNDM is mandatory for technical units issuing the CCT, and only the name of the issuing institution differs |
| Decreto Ejecutivo N° 490 | Article 21 | The CCT is issued by the DNDM or by an authorised technical unit |
| Decreto Ejecutivo N° 490 | Article 4, item 4 | DNDM function: to authorise technical units to take part in management, vigilance and control |
| Decreto Ejecutivo N° 490 | Article 2, definition 93 | Definition of technical unit in the DE 490 version |
3. Expert insights
Insight one: the technical unit system is Panama’s answer to limited review capacity. Article 8 of DE 490 names two existing units by way of example: the health technology department of the Social Security Fund (Caja de Seguro Social) and the central public health reference laboratory of the Gorgas Memorial Institute. Bringing technical capacity from inside the public health system into the regulatory chain is unusual in Central America. For companies, it means the technical review of a CCT may be carried out by an institution with clinical experience of using the products, so the questions asked tend to follow actual conditions of use rather than document form alone.
Insight two: authorisation must be given by resolution, which makes it verifiable. The closing sentence of Article 8 provides that the function must be authorised by resolution. The authorisation status of a technical unit can therefore be checked against the MINSA record. When a company works with an intermediary that offers to obtain a CCT on its behalf, the resolution number should be verified rather than the claim accepted. This is a short check that separates an authorised channel from an arrangement that has no legal basis, and it should be performed before any payment is made.
Insight three: the form is uniform, while the issuing institution is not. The second paragraph of Article 10 makes the DNDM form mandatory for technical units, with only the heading differing. The rule protects the formal consistency of the CCT and means that a company does not have to redesign its submission because a different body is receiving it. The real difference between issuers lies in the review, not in the form. Teams that prepare one version of the file for the DNDM and another for a technical unit are solving a problem that does not exist while missing the one that does.
Insight four: one function of the technical unit is easily overlooked, namely the upward move on reconsideration. Article 9, item 2, subparagraph b provides that when a supplier files a request for reconsideration (reconsideración) of a technical criteria assessment, the technical unit must send the file to the DNDM for re-evaluation. A reconsideration is therefore not absorbed inside the unit that issued the assessment; it moves up a level. For a company that has received an unfavourable conclusion, the route is defined, and the body that hears it sits above the body that decided.
4. Practical recommendations
- Before submission, confirm whether the CCT will be received by the DNDM or by an authorised technical unit, and verify the authorising resolution for the unit.
- Use the current DNDM form version for all material. Do not create a substitute form because the receiving body is different.
- Route review queries and corrections through the channel of the receiving body only, so that the file does not acquire conflicting statuses from parallel correspondence.
- On an unfavourable conclusion, use the reconsideration route in Article 9, item 2, subparagraph b and move the file to the DNDM for re-evaluation.
- Archive every written exchange with the technical unit, since that record becomes the evidentiary base for any later reconsideration or remedy.
5. Verification checklist
- □ Confirm whether the receiving body is the DNDM or an authorised technical unit
- □ Verify the resolution number authorising the technical unit (Article 8)
- □ Use the current mandatory DNDM form version (Article 10)
- □ Record the 5 functions of the technical unit (Article 9)
- □ Confirm the reconsideration route moves the file to the DNDM for re-evaluation (Article 9, item 2, subparagraph b)
- □ Archive all written correspondence
Regulatory information verified to 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registrations through the DIGEMID-equivalent medical device directorate, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us